Galectin Therapeutics (GALT) Files 2M Share Stock Shelf for Selling Shareholders

August 16, 2016 8:54 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Galectin Therapeutics (Nasdaq: GALT) filed a registration with the U.S. SEC to sell up to 2 million shares of common stock on behalf of selling shareholders.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment